Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Accumulated Expenses: 2012-2025

Historic Accumulated Expenses for Prothena Corp Public (PRTA) over the last 13 years, with Sep 2025 value amounting to $17.6 million.

  • Prothena Corp Public's Accumulated Expenses rose 70.35% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year increase of 70.35%. This contributed to the annual value of $13.4 million for FY2024, which is 8.80% down from last year.
  • Per Prothena Corp Public's latest filing, its Accumulated Expenses stood at $17.6 million for Q3 2025, which was down 41.93% from $30.3 million recorded in Q2 2025.
  • Over the past 5 years, Prothena Corp Public's Accumulated Expenses peaked at $30.3 million during Q2 2025, and registered a low of $5.3 million during Q3 2021.
  • Over the past 3 years, Prothena Corp Public's median Accumulated Expenses value was $15.9 million (recorded in 2024), while the average stood at $16.7 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 118.12% in 2022, then plummeted by 42.57% in 2024.
  • Prothena Corp Public's Accumulated Expenses (Quarterly) stood at $6.4 million in 2021, then skyrocketed by 69.96% to $10.8 million in 2022, then surged by 36.41% to $14.7 million in 2023, then dropped by 8.80% to $13.4 million in 2024, then surged by 70.35% to $17.6 million in 2025.
  • Its Accumulated Expenses stands at $17.6 million for Q3 2025, versus $30.3 million for Q2 2025 and $12.7 million for Q1 2025.